证券记录 · 已归档季度
NVO
Novo Nordisk A/S · Healthcare · Drug Manufacturers - General
17被追踪持有人
-1Δ持有人
53.30M持有股份
$3.68B报告持仓市值
+1新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 -5.6% ·
股份流向 -13.2% ·
净新建仓位 -5.9%
· 公式
广泛减持：持股数量下降，持有人数量减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 347.39K | $13.21M | n/a | −1 |
| Q2 2026 | 132 | 0 | 235.88M | $11.31B | +12 | −13 |
| Q1 2026 | 134 | -8 | 242.80M | $8.91B | +5 | −13 |
| Q4 2025 | 140 | +1 | 228.46M | $11.63B | +3 | −2 |
| Q3 2025 | 19 | -1 | 80.89M | $4.49B | +2 | −3 |
| Q2 2025 | 17 | -1 | 53.30M | $3.68B | +1 | −2 |
| Q1 2025 | 16 | 0 | 43.10M | $3.00B | n/a | n/a |
| Q4 2024 | 16 | -1 | 48.20M | $4.15B | +1 | −2 |
| Q3 2024 | 16 | -1 | 43.13M | $5.09B | +1 | −2 |
| Q2 2024 | 17 | n/a | 46.04M | $6.57B | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 13.94M | n/a | $962.22M | 0.1% | n/c | 1 | SEC ↗ ×5 |
| 2 | Fisher Asset Management ✦ | 11.00M | -7.3% | $759.28M | 0.3% | ▼ Trim | 5 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 6.20M | +16.5% | $428.15M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (被动) | 6.05M | +0.8% | $418.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 4.94M | -27.6% | $340.74M | 0.5% | ▼ Trim | 5 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 4.36M | n/a | $300.80M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 7 | Markel Group ✦ | 2.26M | +5.0% | $155.89M | 1.3% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | Two Sigma Investments ✦ | 2.22M | -29.6% | $153.01M | 0.3% | ▼ Trim | 3 | SEC ↗ |
| 9 | Tiger Global Management ✦ | 1.27M | 0.0% | $87.59M | 0.3% | Held | 5 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 396.47K | -76.9% | $27.36M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | Wellington Management ✦ | 260.62K | -74.5% | $17.99M | 0.0% | ▼ Trim | 4 | SEC ↗ ×5 |
| 12 | Capital World Investors ✦ | 215.69K | +3.8% | $14.78M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 125.45K | +102.0% | $8.66M | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 14 | Millennium Management ✦ | 35.66K | -96.0% | $2.46M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 15 | Marshall Wace ✦ | 31.20K | +24.2% | $2.15M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | GAMCO Investors ✦ | 4.54K | 新增 | $313,627 | 0.0% | New | 1 | SEC ↗ |
| 17 | Baillie Gifford ✦ | 130 | -26.1% | $8,973 | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| GAMCO Investors | $313,627 | 0.0% |
已清仓
| D. E. Shaw & Co. | $179.33M | 曾为 0.2% |
| Arrowstreet Capital | $745,647 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 1.21M 股份, $43.09M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据